Research snapshot
Biolaminin 521 supports animal origin-free hESC-RPE differentiation and retinal rescue
Backstory
Retinal pigment epithelium (RPE) is a single layer of specialized cells located between the photoreceptors and Bruch’s membrane, where it supports vision by absorbing excess light, secreting growth factors, and phagocytosing of photoreceptor cell fragments.
Age-related macular degeneration (AMD) is one of the most common causes of vision loss in developed countries. In early dry AMD, the RPE cells become dysfunctional, and in end-stage disease, RPE and photoreceptors degenerate. Stem cell-derived RPE transplants may hold great promise for cell replacement therapy. However, earlier transplantation studies using human embryonic stem cell (hESC)-derived RPE were limited to small-animal models, and the production of hESC-RPE has not yet been achieved in an animal origin–free and fully defined manner, which is critical for clinical compliance and reduced immunogenicity.
The study by Reyes et al. (2016) addresses these limitations by describing an efficient, fully defined hESC-RPE differentiation protocol using Biolaminin 521.
How laminins helped
Animal origin-free, defined culture medium using Biolaminin 521 efficiently supported the first stage of hESC-RPE differentiation into early pigmented structures resembling optical vesicles.
Among the tested substrates for subsequent expansion and maturation, Biolaminin 521 outperformed gelatin and other laminin isoforms in supporting efficient expansion, uniform migration, and formation of a continuous, polarized RPE monolayer with native characteristics, including pigmentation, marker expression, tight junction integrity, and phagocytic activity. hESC-RPE grown on Biolaminin 521 and transplanted as a cell suspension into albino rabbit eyes survived, integrated into the host RPE, matured in vivo, and remained stable long term while preserving retinal structure. Importantly, photoreceptor rescue was both specific and sensitive, as protection occurred only with properly differentiated and integrated Biolaminin 521–grown RPE cells, whereas non-RPE cells or non-integrated grafts were ineffective.
The bigger picture
This study demonstrates that combining a fully defined, animal origin-free culture medium with a physiologically relevant extracellular matrix is key to generating clinically compliant RPE cells. Biolaminin 521 not only replaces undefined or animal-derived matrices but provides superior support for hESC-RPE differentiation, maturation, and function. Importantly, the work shows that hESC-RPE produced under animal origin-free conditions can be delivered using a minimally invasive surgical approach, integrate long term, and preserve photoreceptors in a large-eyed disease model. Together, these findings strengthen the translational relevance of hESC-RPE therapy and have important implications for the safe and effective development of cell replacement treatments for geographic atrophy.
Product used in this study:
-
Biolaminin 521 LN (LN521)
Full-length human recombinant laminin-521
Biolaminin 521 LN is a full-length laminin-521 substrate—the natural laminin for pluripotent stem cells, reliably facilitating ESC and iPSC self-r […]